Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00317 | 35140487 | Diabetes Metab Syndr Obes | The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. | 2022 | Details |
| A00318 | 35140289 | Sci Rep | Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway. | 2022 | Details |
| A00319 | 35138995 | Pharm Biol | Jinlida granules ameliorate the high-fat-diet induced liver injury in mice by antagonising hepatocytes pyroptosis. | 2022 | Details |
| A00320 | 35138548 | Intern Emerg Med | NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study. | 2022 | Details |
| A00321 | 35137416 | J Cell Physiol | The role of exosomal miRNA in nonalcoholic fatty liver disease. | 2022 | Details |
| A00322 | 35136128 | Sci Rep | Favorable association between Mediterranean diet (MeD) and DASH with NAFLD among Iranian adults of the Amol Cohort Study (AmolCS). | 2022 | Details |
| A00323 | 35135742 | Dig Liver Dis | Intrahepatic lipid content is independently associated with soluble E-selectin levels: The Maastricht study. | 2022 | Details |
| A00324 | 35134508 | J Nutr Biochem | Mechanisms of autophagic responses to altered nutritional status. | 2022 | Details |
| A00325 | 35134507 | J Nutr Biochem | Green tea extract increases adiponectin and PPAR α levels to improve hepatic steatosis. | 2022 | Details |
| A00326 | 35134438 | Life Sci | Fluorene-9-bisphenol exposure decreases locomotor activity and induces lipid-metabolism disorders by impairing fatty acid oxidation in zebrafish. | 2022 | Details |
| A00327 | 35134388 | Anal Biochem | Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies. | 2022 | Details |
| A00329 | 35133671 | Hepatology | Randomized placebo-controlled trial of losartan for pediatric NAFLD. | 2022 | Details |
| A00330 | 35133148 | J Agric Food Chem | Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. | 2022 | Details |
| A00331 | 35133139 | Environ Sci Technol | 3-tert-Butyl-4-hydroxyanisole Impairs Hepatic Lipid Metabolism in Male Mice Fed with a High-Fat Diet. | 2022 | Details |
| A00332 | 35133032 | FASEB J | TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk. | 2022 | Details |
| A00333 | 35132345 | Oxid Med Cell Longev | Differentially Expressed Hepatic Genes Revealed by Transcriptomics in Pigs with Different Liver Lipid Contents. | 2022 | Details |
| A00334 | 35131122 | Clin Investig Arterioscler | Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path! | 2022 | Details |
| A00335 | 35130757 | Biol Res Nurs | Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00336 | 35130181 | Aging (Albany NY) | Cholesterol metabolism in aging simultaneously altered in liver and nervous system. | 2022 | Details |
| A00337 | 35129841 | Hepatol Res | The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease. | 2022 | Details |
| A00338 | 35129307 | Liver Int | Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models. | 2022 | Details |
| A00339 | 35129295 | Liver Int | Differential fuel utilization in liver transplant recipients and its relationship with non-alcoholic fatty liver disease. | 2022 | Details |
| A00340 | 35129258 | Liver Int | The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint. | 2022 | Details |
| A00341 | 35127789 | Front Nutr | Lentinan Supplementation Protects the Gut-Liver Axis and Prevents Steatohepatitis: The Role of Gut Microbiota Involved. | 2022 | Details |
| A00342 | 35127372 | Acta Pharm Sin B | The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. | 2021 | Details |
| A00343 | 35127371 | Acta Pharm Sin B | Therapeutic regulation of autophagy in hepatic metabolism. | 2021 | Details |
| A00344 | 35126846 | World J Hepatol | Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. | 2022 | Details |
| A00345 | 35126845 | World J Hepatol | Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible? | 2022 | Details |
| A00346 | 35126843 | World J Hepatol | Is there a role of lipid-lowering therapies in the management of fatty liver disease? | 2022 | Details |
| A00347 | 35126317 | Front Endocrinol (Lausanne) | Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014. | 2022 | Details |
| A00348 | 35126113 | Front Pharmacol | Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice. | 2022 | Details |
| A00350 | 35124887 | Mol Nutr Food Res | ChREBP-driven DNL and PNPLA3 Expression Induced by Liquid Fructose are Essential in the Production of Fatty Liver and Hypertriglyceridemia in a High-Fat Diet-Fed Rat Model. | 2022 | Details |
| A00352 | 35124446 | J Pharm Biomed Anal | Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS. | 2022 | Details |
| A00353 | 35124270 | Clin Gastroenterol Hepatol | Influence of Nonalcoholic Fatty Liver Disease With Elevated Liver Enzyme Levels on Risk of Cirrhosis and Hepatocellular Carcinoma. | 2022 | Details |
| A00354 | 35124268 | Clin Gastroenterol Hepatol | Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19. | 2022 | Details |
| A00355 | 35123096 | Clin Gastroenterol Hepatol | Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD. | 2022 | Details |
| A00356 | 35122619 | J Physiol Biochem | Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis : Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis. | 2022 | Details |
| A00357 | 35122420 | Pediatr Obes | Exposure to maternal fuels during pregnancy and offspring hepatic fat in early childhood: The healthy start study. | 2022 | Details |
| A00358 | 35122118 | Semin Immunopathol | TNF in the liver: targeting a central player in inflammation. | 2022 | Details |
| A00359 | 35121786 | Sci Rep | Pericardial fat, thoracic peri-aortic adipose tissue, and systemic inflammatory marker in nonalcoholic fatty liver and abdominal obesity phenotype. | 2022 | Details |
| A00360 | 35120767 | Med Clin (Barc) | Bariatric surgery and non-alcoholic fatty liver disease. | 2022 | Details |
| A00361 | 35120381 | Semin Liver Dis | The Role of Liver Zonation in Physiology, Regeneration, and Disease. | 2022 | Details |
| A00362 | 35120274 | Hepatol Res | Perturbation of Wnt/β-catenin signaling and sexual dimorphism in non-alcoholic fatty liver disease. | 2022 | Details |
| A00363 | 35119232 | J Basic Clin Physiol Pharmacol | Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. | 2022 | Details |
| A00364 | 35118444 | touchREV Endocrinol | Potential Role of Dexamphetamine in the Treatment of Non-alcoholic Fatty Liver Disease: Hopes and Pitfalls. | 2021 | Details |
| A00365 | 35116640 | Transl Cancer Res | Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease. | 2021 | Details |
| A00366 | 35116505 | Transl Cancer Res | Low expression of AQP9 and its value in hepatocellular carcinoma. | 2021 | Details |
| A00367 | 35115947 | Front Pharmacol | Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A00368 | 35115798 | Diabetes Metab Syndr Obes | Association of Circulating TXNIP Levels with Fatty Liver in Newly Diagnosed Type 2 Diabetes Mellitus. | 2022 | Details |
| A00369 | 35115689 | Nat Genet | Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort. | 2022 | Details |
| A00370 | 35115498 | Cell Death Discov | Bdh1 overexpression ameliorates hepatic injury by activation of Nrf2 in a MAFLD mouse model. | 2022 | Details |
| A00371 | 35114889 | Organogenesis | Therapeutic Potential of HNF4α in End-stage Liver Disease. | 2021 | Details |
| A00372 | 35114586 | Biochem Biophys Res Commun | Estrogen receptor α mediated M1/M2 macrophages polarization plays a critical role in NASH of female mice. | 2022 | Details |
| A00373 | 35113098 | Food Funct | Curcumin alleviates hepatic steatosis by improving mitochondrial function in postnatal overfed rats and fatty L02 cells through the SIRT3 pathway. | 2022 | Details |
| A00374 | 35112237 | Handb Exp Pharmacol | The Circadian Clock and Obesity. | 2022 | Details |
| A00375 | 35111794 | Front Nutr | Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A00376 | 35111769 | Front Med (Lausanne) | Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults. | 2022 | Details |
| A00377 | 35111690 | Front Cell Infect Microbiol | Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. | 2022 | Details |
| A00378 | 35111461 | Cureus | Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A00379 | 35110952 | World J Gastroenterol | Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. | 2022 | Details |
| A00380 | 35109946 | Nutr Res Rev | NAFLD and vitamin D: Evidence for intersection of microRNA-regulated pathways. | 2021 | Details |
| A00381 | 35109888 | Trials | Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial. | 2022 | Details |
| A00382 | 35108509 | Cell Metab | New avenues for NASH therapy by targeting ACC. | 2022 | Details |
| A00383 | 35108454 | FEBS Open Bio | Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation. | 2022 | Details |
| A00384 | 35108315 | PLoS One | Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency. | 2022 | Details |
| A00385 | 35107763 | Curr Atheroscler Rep | Childhood Hypertriglyceridemia: Is It Time for a New Approach? | 2022 | Details |
| A00386 | 35107741 | Mol Biol Rep | Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling. | 2022 | Details |
| A00387 | 35107488 | Arq Bras Cir Dig | OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES. | 2022 | Details |
| A00388 | 35106510 | Cell Rep Med | Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism. | 2022 | Details |
| A00389 | 35104782 | Ecotoxicol Environ Saf | Chronic lead exposure induces fatty liver disease associated with the variations of gut microbiota. | 2022 | Details |
| A00390 | 35104757 | Phytomedicine | Seed oil of Rosa roxburghii Tratt against non-alcoholic fatty liver disease in vivo and in vitro through PPARα/PGC-1α-mediated mitochondrial oxidative metabolism. | 2022 | Details |
| A00391 | 35104330 | Diabetes Care | Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes. | 2022 | Details |
| A00392 | 35103461 | Minerva Endocrinol (Torino) | Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders. | 2022 | Details |
| A00393 | 35102341 | Nat Metab | PSD3 downregulation confers protection against fatty liver disease. | 2022 | Details |
| A00394 | 35102183 | Sci Rep | Intergenerational effects of preconception opioids on glucose homeostasis and hepatic transcription in adult male rats. | 2022 | Details |
| A00395 | 35102146 | Nat Commun | Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis. | 2022 | Details |
| A00396 | 35102112 | Eur J Gastroenterol Hepatol | Clinical implications of hepatic structure and function evaluation based on vibration-controlled transient elastography and liver maximum function capacity test in patients with nonalcoholic fatty liver disease. | 2022 | Details |
| A00397 | 35101634 | Clin Gastroenterol Hepatol | Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression. | 2022 | Details |
| A00398 | 35101633 | Clin Gastroenterol Hepatol | Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00399 | 35101037 | BMC Med | Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations. | 2022 | Details |
| A00400 | 35100965 | Mol Med | Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1. | 2022 | Details |
| A00401 | 35100585 | Ann Nutr Metab | Influences of vitamin D levels and vitamin D binding protein polymorphisms on non-alcoholic fatty liver disease risk in a Chinese population. | 2022 | Details |
| A00402 | 35100462 | Diabet Med | An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care. | 2022 | Details |
| A00403 | 35100057 | Metab Syndr Relat Disord | Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V. | 2022 | Details |
| A00404 | 35100024 | Circulation | Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3. | 2022 | Details |
| A00405 | 35098442 | Hepatol Int | Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review. | 2022 | Details |
| A00406 | 35097198 | AACE Clin Case Rep | Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. | 2021 | Details |
| A00407 | 35096933 | Front Nutr | Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation. | 2022 | Details |
| A00408 | 35096879 | Front Med (Lausanne) | Liver Steatosis: Better Predictor of CKD in MAFLD Than Liver Fibrosis as Determined by Transient Elastography With Controlled Attenuation Parameter. | 2022 | Details |
| A00409 | 35096868 | Front Med (Lausanne) | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. | 2022 | Details |
| A00410 | 35096103 | Evid Based Complement Alternat Med | Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking. | 2022 | Details |
| A00411 | 35094409 | Med Phys | Vibration-controlled transient elastography for noninvasive evaluation of liver steatosis. | 2022 | Details |
| A00412 | 35093608 | Mol Cell Proteomics | Integrated liver and plasma proteomics in obese mice reveals complex metabolic regulation. | 2022 | Details |
| A00413 | 35093393 | Biochem Pharmacol | Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease. | 2022 | Details |
| A00414 | 35093339 | Life Sci | Endothelial group IVA phospholipase A2 promotes hepatic fibrosis with sinusoidal capillarization in the early stage of non-alcoholic steatohepatitis in mice. | 2022 | Details |
| A00415 | 35093101 | J Transl Med | Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro. | 2022 | Details |
| A00416 | 35092912 | EBioMedicine | The influence of host genetics on liver microbiome composition in patients with NAFLD. | 2022 | Details |
| A00418 | 35092183 | Pediatr Obes | Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity. | 2022 | Details |
| A00419 | 35091842 | Dig Dis Sci | Validation and Performance of FibroScan®-AST (FAST) Score on a Brazilian Population with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00420 | 35091821 | Diabetologia | Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice. | 2022 | Details |